TGM2 and pancreatic neoplasm: Similar results were observed in pancreatic-tumor-bearing mice treated with gemcitabine with or without TG2-specific siRNA-DOPC (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine) liposomes [46].